Posted on Thu, Aug 12, 2010 @ 10:41 AM
Biosearch Technologies today announces that it has entered into a new license relationship with QIAGEN (NASDAQ: QIA, Frankfurt Prime Standard) providing broad commercialisation rights to Scorpions Primers. This agreement allows Biosearch the right to manufacture, catalog, and sell Scorpions primer assays into the research, applied, and infectious disease testing markets.
To read the entire story, read the full press release.
Posted on Thu, Aug 05, 2010 @ 10:07 AM
Biosearch Technologies today announces the company has licensed exclusively from the University of Medicine and Dentistry of New Jersey (UMDNJ) a Single Molecule Fluorescent in-situ hybridization technology based on detection of RNA. Biosearch owns the exclusive rights to manufacture, catalogue and sell validated RNA FISH probes, assays and kits into the Research, Applied Markets and IVD fields under the UMDNJ technologies and patent applications.
To read the entire story, read the full press release.
Posted on Tue, Apr 06, 2010 @ 10:52 AM
We are pleased to introduce ValuPanel Reagents, a new product line of mission-critical probe and primer sets that discriminate different strains of pathogens. This product line culminated from our successful collaboration with Centers for Disease Control and Prevention* (CDC) in response to the 2009 H1N1 pandemic. As of now, ValuPanel Reagents are available for both 2009 H1N1 and seasonal Influenza A subtyping.
*CDC does not endorse products or services.
The Details:
Probes are labeled with FAM and BHQ® dyes and all probes and primers are HPLC purified. ValuPanel Reagents are available with same day shipping via FedEx Priority for all orders placed before 2 PM (PST). ValuPanel Reagents are for Research Use Only (RUO) and currently resolve genetic signatures specific to the following viruses and subtypes:
2009 H1N1
- InfA for the universal detection of influenza A
- swInfA for the specific detection of swine influenza A
- swH1 for the specific detection of swine influenza H1
- RNase P for a positive control
Influenza A Subtyping
- InfA - for the universal detection of influenza A
- H1 subtype of influenza A
- H3 subtype of influenza A
- H5a subtype of influenza A
- H5b subtype of influenza A
- InfB - for the universal detection of influenza B
- RNase P for a positive control
Probe pricing for ValuPanel Reagents start from $135.00 and provide 5 nmol delivered. Forward and reverse primers are each available for $14.00 and provide 20 nmol delivered.
Learn more about Biosearch's NEW ValuPanel Reagents:
Posted on Tue, Mar 09, 2010 @ 11:37 AM
Biosearch Technologies today announces that the company has expanded its licenses from Roche Molecular Systems, Inc. (Roche). The expanded license grants Biosearch the right to manufacture and sell validated kits to the in-vitro diagnostic (IVD) marketingplace as licensed products convered by multiple patents assigned to Roche.
To read the entire story, read the full press release.
Posted on Wed, Mar 03, 2010 @ 03:50 PM
Biosearch Technologies announced today that it has been awarded new patents related to luminescent metal chelate and novel enzymatic reporter system. These patents demonstrate Biosearch's continued advancement in the field of pro-fluorescent assays.
To read the entire story, read the full press release.
Posted on Thu, Dec 03, 2009 @ 10:57 AM
To celebrate the end of the year, we are offering a holiday promotion to our blog readers, Twitter followers, and Facebook fans. Spend a minimum of $500 at Biosearchtech.com and receive a 10% discount* off your online order. Simply enter the one-time use promotional code HOLIDAY09 upon checkout. Submit your order soon as this offer lasts until December 31, 2009. For more promotional details, please visit: www.biosearchtech.com/holiday09.
Don't forget that Biosearch Technologies offers a variety of products such as dual-labeled probes and primers, custom oligonucleotides with a wide variety of modifications, DNA/RNA synthesis reagents such as amidites, columns and CPGs, labeling reagents, and immunochemicals such as hapten reporter groups and other conjugates. You can access our complete product offerings by accessing our Products menu on our website.
*Promotion is valid for online orders and for one-time use only; Offer expires December, 31 2009; Promotion not valid when combined with other offers or discounts; 10% discounts will be applied to online orders with a total of $500 or more.
Posted on Wed, Nov 04, 2009 @ 09:47 AM
Biosearch Technologies announced today that the company has licensed from the CDC the novel H1N1 Influenza signatures along with the Influenza A sub-typing panel signatures. This licensing agreement with the CDC makes Biosearch Technologies the first oligo manufacturer to have the right to manufacture and sell dual-labeled probes and primers bearing the H1N1 and Influenza A sub-typing signatures.
To read the entire story, read the full press release.
Posted on Wed, Oct 28, 2009 @ 03:16 PM
Micronics, Inc., a leading developer of point-of-care molecular diagnostic products, announced today that it has entered into a license agreement with Biosearch Technologies, Inc. for the right to make, have made, use and sell Micronics' products that incorporate Biosearch's proprietary fluorophores and quencher dyes for nucleic acid assays. Under the terms of the worldwide license, Biosearch has granted Micronics a royalty-free use of certain of its chemistries for inclusion in Micronics' infectious disease tests for sale in underdeveloped countries.
To read the entire story, read the full press release.
Posted on Thu, Oct 01, 2009 @ 09:08 AM
Biosearch Technologies has ground breaking news to announce today. We licensed a family of patents covering practice of the 5' Nuclease process from Roche Molecular Systems (Roche). The Roche license provides freedom to operate, with respect to the Roche IP estate, for qPCR processes in the Diagnostic Research Field. This license makes Biosearch the first commercial oligonucleotide manufacturer to take the Roche license, which gives Biosearch the right to manufacture and sell dual-labeled probes for use in 5' Nuclease assays for internal research in the diagnostics field.
Click here to read the actual press release regarding Biosearch's licensing agreement with Roche Molecular Systems.
To learn about our services for the Molecular Diagnostics industry, visit our webpage, OUTSOURCE: Oligos for Molecular Diagnostics.
Posted on Tue, Sep 22, 2009 @ 05:23 PM
Biosearch Technologies has received a complaint for alleged patent infringement filed in the U.S. District Court for the Eastern District of Texas on September 18, 2009, by Life Technologies Corp. and Applied Biosystems, LLC.
As a company that prides itself on developing and safeguarding innovative technology in its own right, Biosearch has always been, and continues to be, respectful of the intellectual property of others. Biosearch is also protective and mindful of its own intellectual property rights and proprietary product lines. Biosearch does not believe there is any merit to the claims made by Life Technologies Corp. or Applied Biosystems, LLC, and will defend itself vigorously against these charges. Biosearch President and CEO, Ron Cook, comments, "Biosearch has been making and selling dual labeled quencher probes since 1998 so this is territory we know quite well. We are confident that the lawsuit is baseless and will aggressively defend our technology and our company."
Biosearch sees no impact on the supply of its products to customers as a result of this action.